Perfil
Jon Adkins is the founder of XenoTherapeutics, Inc. and holds the title of President & Executive Director.
He is also the founder of Alexis Bio LLC and holds the title of Director.
Cargos activos de Jon Adkins
Empresas | Cargo | Inicio |
---|---|---|
XenoTherapeutics, Inc.
XenoTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services XenoTherapeutics, Inc. engages in xenotransplantation treatment services. It offers Xeno-Skin which is a humanitarian device for the treatment of severe burns and chronic wounds. The company was founded by Paul Holzer and Jon Adkins and is headquartered in Boston, MA. | Fundador | - |
Alexis Bio LLC
Alexis Bio LLC BiotechnologyHealth Technology Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH. | Fundador | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
XenoTherapeutics, Inc.
XenoTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services XenoTherapeutics, Inc. engages in xenotransplantation treatment services. It offers Xeno-Skin which is a humanitarian device for the treatment of severe burns and chronic wounds. The company was founded by Paul Holzer and Jon Adkins and is headquartered in Boston, MA. | Commercial Services |
Alexis Bio LLC
Alexis Bio LLC BiotechnologyHealth Technology Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH. | Health Technology |
- Bolsa de valores
- Insiders
- Jon Adkins